|1.||Hoffman, T J: 1 article (12/2001)|
|2.||Jurisson, S S: 1 article (12/2001)|
|3.||Quinn, T P: 1 article (12/2001)|
|4.||Cheng, Z: 1 article (12/2001)|
|5.||Miao, Y: 1 article (12/2001)|
|6.||Chen, J: 1 article (12/2001)|
|7.||Owen, N K: 1 article (12/2001)|
|1.||Melanoma (Melanoma, Malignant)
12/01/2001 - "The novel ReO-coordinated cyclic structure of DOTA-ReCCMSH contributes significantly to its enhanced tumor-targeting and renal clearance properties and makes DOTAReCCMSH an excellent candidate for melanoma radiodetection and radiotherapy."
12/01/2001 - "The aim of this study was to examine the effect of rhenium-mediated peptide cyclization on melanoma targeting, biodistribution, and clearance kinetics of the alpha-melanocyte-stimulating hormone (alpha-MSH) analog 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) coupled ReO-cyclized [Cys(3,4,10),D-Phe(7)]alpha-MSH(3-13) (DOTA-ReCCMSH). "
|3.||1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid